Ashland — Nov 4, 2025 release

Ashland completed its Portfolio Optimization with the sale of the Avoca business and implemented $30 million in restructuring cost savings. Significant progress was made on manufacturing network optimization, with the $60 million program well advanced and further productivity opportunities under evaluation. Ashland continued to invest in globalization, accelerating growth across several high-quality businesses. Innovation driven growth enriched the technology portfolio and capabilities, including an asset repurpose strategy to efficiently scale innovation. Disciplined capital allocation remained a core focus, as Ashland executed to maintain a strong and flexible balance sheet, optimize the portfolio, and deliver value to shareholders. Collectively, these initiatives strengthen Ashland’s foundation and position the company to deliver durable growth and long-term shareholder value.   Financial Outlook   Ashland is issuing the following guidance for fiscal 2026. The company intends to deliver against these commitments with a focus on execution, consistency, and credibility.   Full-year fiscal 2026 guidance • Sales: $1,835 million to $1,905 million , reflecting organic growth of approximately one to five percent over the prior year • Adjusted EBITDA: $400 million to $430 million • Adjusted Diluted Earnings Per Share Excluding Intangibles Amortization Expense growth: double-digit-plus; reflecting operating impr